Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15554 | 706 | 37.8 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
285 | 3 | ERDOSTEINE//PEROXIREDOXIN//GLUTATHIONE | 42405 |
2589 | 2 | VITAMIN C//ASCORBIC ACID//SVCT2 | 3640 |
15554 | 1 | NUTRIENT MIXTURE//AUTOSCHIZIS//MATRIGEL INVASION | 706 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NUTRIENT MIXTURE | authKW | 721815 | 3% | 76% | 22 |
2 | AUTOSCHIZIS | authKW | 540618 | 2% | 83% | 15 |
3 | MATRIGEL INVASION | authKW | 316325 | 2% | 46% | 16 |
4 | MOL CLIN NUTR SECT | address | 227235 | 2% | 31% | 17 |
5 | ASCORBYL STEARATE | authKW | 216249 | 1% | 100% | 5 |
6 | INTRAVENOUS VITAMIN C | authKW | 173000 | 1% | 100% | 4 |
7 | PALMITOYL ASCORBATE | authKW | 173000 | 1% | 100% | 4 |
8 | TOXICOL CANC BIOL GRP | address | 148268 | 2% | 29% | 12 |
9 | PRO VITAMIN C | authKW | 129750 | 0% | 100% | 3 |
10 | UNITE PMNT 7369 | address | 129750 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 3374 | 36% | 0% | 257 |
2 | Nutrition & Dietetics | 620 | 8% | 0% | 59 |
3 | Microscopy | 402 | 3% | 0% | 19 |
4 | Medicine, Research & Experimental | 259 | 8% | 0% | 58 |
5 | Integrative & Complementary Medicine | 217 | 2% | 0% | 16 |
6 | Biochemistry & Molecular Biology | 208 | 18% | 0% | 129 |
7 | Cell Biology | 192 | 10% | 0% | 73 |
8 | Pharmacology & Pharmacy | 117 | 10% | 0% | 71 |
9 | Toxicology | 60 | 4% | 0% | 25 |
10 | Endocrinology & Metabolism | 46 | 4% | 0% | 31 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL CLIN NUTR SECT | 227235 | 2% | 31% | 17 |
2 | TOXICOL CANC BIOL GRP | 148268 | 2% | 29% | 12 |
3 | UNITE PMNT 7369 | 129750 | 0% | 100% | 3 |
4 | ATONE DEV | 98853 | 1% | 57% | 4 |
5 | KU INTEGRAT MED | 97311 | 0% | 75% | 3 |
6 | MEIO INC | 86500 | 0% | 100% | 2 |
7 | PHARMACOL TOXICOL CANCEROL | 86500 | 0% | 100% | 2 |
8 | BIOQUIM EXPT | 86492 | 1% | 33% | 6 |
9 | ST GEORGES UNIV INT MED | 57665 | 0% | 67% | 2 |
10 | AKRON MED | 43250 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MORFOLOGIA NORMAL Y PATOLOGICA SECCION A-HISTOLOGIA | 2159 | 0% | 3% | 2 |
2 | ONCOLOGY REPORTS | 1895 | 3% | 0% | 21 |
3 | CANCER BIOCHEMISTRY BIOPHYSICS | 1878 | 1% | 1% | 4 |
4 | FREE RADICAL BIOLOGY AND MEDICINE | 1606 | 3% | 0% | 18 |
5 | ANTICANCER RESEARCH | 1495 | 4% | 0% | 26 |
6 | INTEGRATIVE CANCER THERAPIES | 1477 | 1% | 1% | 4 |
7 | REDOX BIOLOGY | 1452 | 1% | 1% | 4 |
8 | ULTRASTRUCTURAL PATHOLOGY | 1382 | 1% | 0% | 8 |
9 | MEDICAL ONCOLOGY | 1302 | 1% | 0% | 10 |
10 | SCANNING | 1239 | 1% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NUTRIENT MIXTURE | 721815 | 3% | 76% | 22 | Search NUTRIENT+MIXTURE | Search NUTRIENT+MIXTURE |
2 | AUTOSCHIZIS | 540618 | 2% | 83% | 15 | Search AUTOSCHIZIS | Search AUTOSCHIZIS |
3 | MATRIGEL INVASION | 316325 | 2% | 46% | 16 | Search MATRIGEL+INVASION | Search MATRIGEL+INVASION |
4 | ASCORBYL STEARATE | 216249 | 1% | 100% | 5 | Search ASCORBYL+STEARATE | Search ASCORBYL+STEARATE |
5 | INTRAVENOUS VITAMIN C | 173000 | 1% | 100% | 4 | Search INTRAVENOUS+VITAMIN+C | Search INTRAVENOUS+VITAMIN+C |
6 | PALMITOYL ASCORBATE | 173000 | 1% | 100% | 4 | Search PALMITOYL+ASCORBATE | Search PALMITOYL+ASCORBATE |
7 | PRO VITAMIN C | 129750 | 0% | 100% | 3 | Search PRO+VITAMIN+C | Search PRO+VITAMIN+C |
8 | ASCORBATE | 113434 | 9% | 4% | 66 | Search ASCORBATE | Search ASCORBATE |
9 | B16FO MELANOMA | 86500 | 0% | 100% | 2 | Search B16FO+MELANOMA | Search B16FO+MELANOMA |
10 | DOTC2 4510 | 86500 | 0% | 100% | 2 | Search DOTC2+4510 | Search DOTC2+4510 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHEN, Q , POLIREDDY, K , CHEN, P , DONG, RC , (2015) THE UNPAVED JOURNEY OF VITAMIN C IN CANCER TREATMENT.CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 93. ISSUE 12. P. 1055 -1063 | 49 | 75% | 1 |
2 | FRITZ, H , FLOWER, G , WEEKS, L , COOLEY, K , CALLACHAN, M , MCGOWAN, J , SKIDMORE, B , KIRCHNER, L , SEELY, D , (2014) INTRAVENOUS VITAMIN C AND CANCER: A SYSTEMATIC REVIEW.INTEGRATIVE CANCER THERAPIES. VOL. 13. ISSUE 4. P. 280 -300 | 52 | 62% | 9 |
3 | PARROW, NL , LESHIN, JA , LEVINE, M , (2013) PARENTERAL ASCORBATE AS A CANCER THERAPEUTIC: A REASSESSMENT BASED ON PHARMACOKINETICS.ANTIOXIDANTS & REDOX SIGNALING. VOL. 19. ISSUE 17. P. 2141 -2156 | 43 | 69% | 17 |
4 | MA, Y , CHAPMAN, J , LEVINE, M , POLIREDDY, K , DRISKO, J , CHEN, Q , (2014) HIGH-DOSE PARENTERAL ASCORBATE ENHANCED CHEMOSENSITIVITY OF OVARIAN CANCER AND REDUCED TOXICITY OF CHEMOTHERAPY.SCIENCE TRANSLATIONAL MEDICINE. VOL. 6. ISSUE 222. P. - | 30 | 65% | 33 |
5 | HOFFER, LJ , ROBITAILLE, L , ZAKARIAN, R , MELNYCHUK, D , KAVAN, P , AGULNIK, J , COHEN, V , SMALL, D , MILLER, WH , (2015) HIGH-DOSE INTRAVENOUS VITAMIN C COMBINED WITH CYTOTOXIC CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER: A PHASE I-II CLINICAL TRIAL.PLOS ONE. VOL. 10. ISSUE 4. P. - | 34 | 71% | 1 |
6 | WILSON, MK , BAGULEY, BC , WALL, C , JAMESON, MB , FINDLAY, MP , (2014) REVIEW OF HIGH-DOSE INTRAVENOUS VITAMIN C AS AN ANTICANCER AGENT.ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. VOL. 10. ISSUE 1. P. 22 -37 | 38 | 54% | 13 |
7 | ERUDAITIUS, D , HUANG, A , KAZMI, S , BUETTNER, GR , RODGERS, VGJ , (2017) PEROXIPORIN EXPRESSION IS AN IMPORTANT FACTOR FOR CANCER CELL SUSCEPTIBILITY TO THERAPEUTIC H2O2: IMPLICATIONS FOR PHARMACOLOGICAL ASCORBATE THERAPY.PLOS ONE. VOL. 12. ISSUE 1. P. - | 25 | 69% | 0 |
8 | CHEN, P , YU, J , CHALMERS, B , DRISKO, J , YANG, J , LI, BY , CHEN, Q , (2012) PHARMACOLOGICAL ASCORBATE INDUCES CYTOTOXICITY IN PROSTATE CANCER CELLS THROUGH ATP DEPLETION AND INDUCTION OF AUTOPHAGY.ANTI-CANCER DRUGS. VOL. 23. ISSUE 4. P. 437 -444 | 28 | 54% | 17 |
9 | PUTCHALA, MC , RAMANI, P , SHERLIN, HJ , PREMKUMAR, P , NATESAN, A , (2013) ASCORBIC ACID AND ITS PRO-OXIDANT ACTIVITY AS A THERAPY FOR TUMOURS OF ORAL CAVITY - A SYSTEMATIC REVIEW.ARCHIVES OF ORAL BIOLOGY. VOL. 58. ISSUE 6. P. 563-574 | 21 | 62% | 19 |
10 | VUYYURI, SB , RINKINEN, J , WORDEN, E , SHIM, H , LEE, S , DAVIS, KR , (2013) ASCORBIC ACID AND A CYTOSTATIC INHIBITOR OF GLYCOLYSIS SYNERGISTICALLY INDUCE APOPTOSIS IN NON-SMALL CELL LUNG CANCER CELLS.PLOS ONE. VOL. 8. ISSUE 6. P. - | 28 | 46% | 19 |
Classes with closest relation at Level 1 |